Cover Image
市場調查報告書

全球內臟器官保存溶液市場

Organ Preservation Solutions

出版商 Global Industry Analysts, Inc. 商品編碼 124548
出版日期 內容資訊 英文 128 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球內臟器官保存溶液市場 Organ Preservation Solutions
出版日期: 2017年07月01日 內容資訊: 英文 128 Pages
簡介

本報告提供全球內臟器官保存溶液市場相關調查,彙整市場趨勢與各市場區隔分析,產品概要,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 序論
    • 主要的推動成長要素
    • 現在及未來市場分析
    • 各地區環境
    • 競爭模式
    • ViaSpan相關污染問題
    • 內臟器官保存技術
    • 單純冷藏保存
    • 連續的低溫或者灌注保存
  • 市場趨勢和推動成長要素
  • 產品概要
    • 內臟器官保存溶液的要素與機能
    • 內臟器官保存溶液的技術性規格
    • 濃縮形態的溶液
    • 內臟器官保存的階段
    • 捐贈者的特定
    • 內臟器官摘出
    • 內臟器官回收與保存
    • 內臟器官保存技術
    • 低體溫
    • 理想保存溶液的必要條件 其他
  • 近幾年的產業活動
  • 主要企業
    • 21st Century Medicine
    • BioLife Solutions, Inc.
    • Dr. Franz Kohler Chemie GmbH
    • Essential Pharmaceuticals, LLC
    • Lifeline Scientific, Inc.
    • Preservation Solutions, Inc.
    • XVIVO Perfusion AB
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
  • 亞太地區
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6177

This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 20 companies including many key and niche players such as -

21st Century Medicine
BioLife Solutions, Inc.
Dr. Franz Kohler Chemie GmbH
Essential Pharmaceuticals, LLC
Lifeline Scientific, Inc.
Preservation Solutions, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Major Growth Drivers in a Gist
  • Key Growth Restraints
    • Table 1: Comparison of Major Organ Preservation Solutions
  • Current & Future Market Analysis
  • Geographic Landscape
  • Competitive Scenario
    • Table 2: Global Organ Preservation Solutions Market (2011 & 2015): Percentage Breakdown of Dollar Sales for Perfadex, Hypo Thermosol, Custodiol(r) HTK, Renograf, Viaspan, and Others (includes corresponding Graph/Chart)
  • Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution
  • XVIVO Sees Brighter Prospects in Organ Preservation Products
  • Contamination Concerns with Regard to ViaSpan(r)
  • Organ Preservation Techniques
  • Simple Cold Storage
  • Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation

2. MARKET TRENDS AND GROWTH DRIVERS

  • Growing Awareness and Policy Support on Transplantation to Benefit Market Growth
  • EVLP: Revolutionary Technique for Lung Preservation
  • New Paradigms in Heart and Lung Preservation
  • Organ Banking: Glimpse into the Future?
  • Preservation Solutions - A Key to Deceased Donor Transplants
  • Euro-Collins Extending Opportunities in the Kidney Segment
  • Cardiac Preservation Scenario Remains Static
  • UW - The Gold Standard in Heart Preservation
  • Innovative Organ Preservation Solutions on the Horizon - A Focus on Leeds Solutions
  • Lungs Preservation in Search of Ideal Solution
  • Scientists See Cryopreservation as a Potential Means for Organ Preservation
  • UW and HTK Find Growing Use in Abdominal Organ Preservation
  • UW Vs. HTK in Liver Transplantation
  • Supercooling Organs - A New Approach to Extend Storage Life
  • Measures to Address Organ Shortage to Infuse Demand for Preservation Solutions
  • Machine Perfusion Gains Popularity over Cold Storage
  • Is Warm Perfusion the Next Standard in Organ Preservation?
  • Key Organ Transplantation Statistics
    • Table 3: Global Kidney Transplant Activity by Source (2016): Number of Kidney Transplants from Living and Deceased Donors for Select Leading Countries (includes corresponding Graph/Chart)
    • Table 4: Global Liver Transplant Activity by Source (2016): Number of Liver Transplants from Living and Deceased Donors for Select Leading Countries (includes corresponding Graph/Chart)
    • Table 5: Global Heart Transplant Activity (2016): Number of Heart Transplants for Select Leading Countries (includes corresponding Graph/Chart)
  • Living Donors on the Rise
  • Graying Population and Chronic Diseases Surge Need for Transplants
    • Table 6: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025P) (includes corresponding Graph/Chart)
  • Transplant Tourism - Creating Brighter Avenues
  • Combined Organ Transplantation - Gaining Attention
    • Table 7: Multiple Organ Transplants in the US - No. of Transplants by Type (2010-2015)
  • Cardiac Arrest Death Patients - The Untapped Potential Donors
    • Table 8: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD): 2016 (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW

  • Elements and Functions of Organ Preservation Solutions
  • Technical Specifications of the Organ Preservation Solutions
  • Solutions in Concentrated Form
  • Steps in Organ Preservation
  • Identification of the Donor
  • Organ Removal
  • Organ Recovery and Preservation
  • Organ Preservation Techniques
  • Hypothermia
  • Requirements of Ideal Preservation Solution
  • Factors Determining Organ Viability
  • Storage Duration Time
  • Storage Time Period for Organs and Tissues
  • Factors Impacting the Organ Preservation
  • Hypothermia Induced Cell Swelling
  • Cellular Acidosis and ATP Usage
  • Compromised Membrane Function
  • Functions of Organ Preservation Solutions
  • Prevention of Reactive Oxygen Species Formation
  • Reduction of Cell Swelling
  • Prevention of Cellular Acidosis
  • Benefits with Colloids
  • Secondary Functions
  • Production and Packaging
  • Production
  • Packaging
  • Tests for Organ Preservation Solutions
  • Hydroxymethylfurfural Test
  • Particulate Contamination
  • Test for Pyrogens
  • Static Cold Storage - The Most Applied and Popular Technique
  • Vitrification - A Promising Cryopreservation Approach for Whole Organs
  • Select Products
  • Euro Collins Solution
    • Table 9: Composition of Euro-Collins Solution (includes corresponding Graph/Chart)
  • University of Wisconsin (UW) Solution
    • Table 10: Composition of UW Solution
  • Custodiol(r) Histidine-Tryptophan-Ketoglutarate (HTK) Solution
    • Table 11: Composition of Custodial HTK Solution
    • Advantages
    • Disadvantages
      • Major Clinical Differences between Custodiol HTK and Viaspan
  • Celsior Solution
    • Table 12: Composition of Celsior Solution
  • Hypothermosol
  • Perfadex(r)
    • Advantages
  • Ross-Marshall Citrate Solutions
  • Phosphate-Buffered Sucrose Solution
  • Lifor
  • IGL-1
  • HBS Solution
  • ET-Kyoto
    • Table 13: Composition of ET-Kyoto Solution
  • Polysol
  • TranSend
  • Background
  • Organ Transplantation
  • A Prelude
  • Heart Transplantation
    • Heart Diseases and Disorders
    • Post-Operative Complications and Consequences of Heart Transplants
  • Kidney Transplantation
    • Kidney Disorders and Diseases
    • Donor Evaluation
    • Waiting List
    • Surgery/Post-Operation
    • Post-Operative Supervision and Issues
  • Liver Transplantation
    • Liver Disorders and Diseases
  • Pancreas Transplantation
    • Post-Operative Complications and Consequences of Pancreas Transplants
  • Small Intestine Transplantation
    • Intestine Disorders and Diseases
  • Heart-and-Lung Transplantation
  • Lung Transplantation
    • Lung Diseases and Disorders
    • Lung Patients Survival Statistics
  • Transplantation Immunology
    • Acute Cellular Rejection
    • Chronic Rejection
  • Post-Transplant Observations
  • Types of Donors
    • Alive Donors
    • Related Donors
    • Good Samaritans
    • Rewarded/Forced Donors
    • Deceased Donors
    • Directed / Allocated
      • Organs Transplanted by Type of Donor
  • Organ Donation and Eligibility Criteria
    • Factors Considered for Matching Recipients to Donor Organs
    • Testing
      • Blood Typing
      • Tissue Typing
  • Issues Impacting Transplantation Market
    • Scarcity of Donor Organs
    • Organ Rejection
    • Other Issues
  • Ethical Concerns and Bioethical Issues
  • Lack of Requisite Expertise
  • Transplantation - Safety Requirements
  • Waiting List
    • Active Waiting List Patients
    • Inactive Waiting List Patients
  • Transplantation Expenses
    • Major Medical and Non-Medical Expenses

4. RECENT INDUSTRY ACTIVITY

  • BioLife and TissueGene Ink Supply Agreement
  • BioLife and Promethera Embed CryoStor into HepaStem Manufacturing
  • BioLife and Bellicum Ink Supply Deal for CryoStor
  • Cook Embeds BioLife's Media Products into Autologous Cell Therapy
  • BioLife and Kite Pharma Ink Supply Agreement
  • Paragonix and Waters Sign Product Supply Agreement
  • Paragonix Technologies Announces Publication of Sherpa Pak(tm) Transport Systems
  • CFDA Approves Organ Preservation Solutions by Lifeline Scientific
  • Provepharm Enters Into Partnership with DFKC

5. FOCUS ON SELECT KEY PLAYERS

  • 21st Century Medicine (USA)
  • BioLife Solutions, Inc. (USA)
  • Dr. Franz Kohler Chemie GmbH (Germany)
  • Essential Pharmaceuticals, LLC (USA)
  • Lifeline Scientific, Inc. (USA)
  • Preservation Solutions, Inc. (USA)
  • XVIVO Perfusion AB (Sweden)

6. GLOBAL MARKET PERSPECTIVE

    • Table 14: World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Organ Preservation Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Increasing Number of Organ Transplants Drives the Organ Preservation Market
    • Table 17: Organ Transplantation in the US by Organ: Number of Transplants for Select Organs for Years 2013-2017 (includes corresponding Graph/Chart)
    • Table 18: US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Table 19: US Liver Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Table 20: US Heart Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Table 21: US Lung Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Table 22: US Pancreas Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Table 23: US Intestinal Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
    • Ever-Increasing Waiting Lists Create Demand for Proper Organ Preservation
    • Table 24: US Waiting List of Patients for Organ Transplants by Organ Type: 2017 (includes corresponding Graph/Chart)
    • Organ Bioengineering and Banking to Unleash New Opportunities
    • New FDA Warning on Contamination Shakes the Market
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 25: US Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 26: US Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 27: Canadian Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: Canadian Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Focus on Select Key Regional Markets
      • Italy
      • The United Kingdom
    • Table 29: Deceased Organ Donations for Transplants in the UK: Number of Organs by Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
    • Table 30: Living Organ Donations for Transplants in the UK: Number of Organs by Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
    • Table 31: UK Active Transplant List by Organ Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 32: European Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: European Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Select Regional Markets
      • Australia
    • Table 34: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart)
    • Table 35: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
      • China
      • Cost Efficiency Lures Transplant Patients from Overseas
      • India
      • Overview of Renal Transplantation
      • Low Transplantation Expenses Boost Medical Tourism
      • Singapore
      • Awareness Programs to Increase Living Kidney Donations in Singapore
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 37: Asia-Pacific Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Select Regional Markets
      • Latin America
      • Brazil - A Major Transplant Market
      • The Middle East
      • Kuwait - A Rapidly Emerging 'Third World' Country in Organ Transplants
      • Iran - "Kidney E-Bay"
  • B. Market Analytics
    • Table 38: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: Rest of World Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top